Blood Glucose Device Market will be USD 19 Billion industry by 2024
15 May, 2018

Get Free Customization in This Report 

Blood Glucose Device Market will be USD 19 Billion industry by the end of year 2024. Growth factors for the global Blood Glucose Device Market device market are the easy reimbursement policies for glucose Test Strips, Lancet & Meters, Increase in the incidence and prevalence of diabetes, Awareness among people with regard to Diabetes. On an average blood glucose device meters are to be changed every 8 to 12 months. This is a costly affair, so people mostly take such insurance plans which partially covers there expenses on medical devices. For example: United States health insurance program Medicare, covers partial reimbursement on medical devices.  

Not only has United States, have almost all Western Europe countries had some formed of diabetes reimbursement schemes. Under these schemes patients suffering from Diabetes get reimbursement on blood glucose device, lancets, test strips and diabetes related drugs.  

Request a free sample copy of the report: https://www.renub.com/contactus.php

Companies operating in Blood Glucose Device Industry

There are various multinational companies such as Roche Diagnostic, Abbott Laboratories, LifeScan Inc., & Bayer HealthCare operating in blood glucose device market. In addition to this various small and medium sized or local companies have also launched their products thus making blood glucose device industry fiercer. According to Renub Research analysis multinational companies are losing their market share to local blood glucose device makers.  

China has Highest Number of Diabetes Population Globally

China accounts for the largest share in Diabetes population globally. Diabetes prevalence in China has shown a meteoric rise from 1 percent in 1980 to a staggering 10 percent in 2017. Primary reasons for the growth in diabetic population are growing disposable income of Chinese, which is leading to more sedentary lifestyle.  According to Renub Research forecast China Diabetic Population is project to be more than 125 Million the end of year 2024.  

Client can Purchase this Report in Sections from below link:

Access full Research: https://www.renub.com/blood-glucose-device-market-and-forecast-smbg-test-strips-lancet-meter-worldwide-analysis-977-p.php

How to Select Proper Blood Glucose Device 

• Check Insurance Coverage: Prior to making a buying choice user should check with their insurance company for its insurance policy coverage fine points. Some insurance providers cover reimbursement for some glucose devices or for few number of test strips.
• Price of Blood Glucose Monitoring Device: Price of glucose monitoring meter differs from model to model. User must also consider the price of test strips before buying.
• Simple to Use: Most of the blood glucose monitoring devices is very user friendly in respect to other devices. The blood glucose meters, lancets, test strips are easy to hold. User can quickly read the numbers coming on its screen.

Reasons which can affect Glucose Reading

• Patient Knowledge: Patient should have complete knowledge of how to use a blood glucose device. Mistake committed by patients in reading the meter can get wrong results.
• Wrong Testing Place: Incorrect food or lotion/ cream left on hands may affect blood glucose reading. Therefore before testing of blood glucose patient should wash and dry their hands. If patient is using disinfects cleaner then he or she makes sure their hands are dried before use.
• Environment: Three factors Room Altitude, Temperature and Humidity affect the result of Blood Glucose testing.  

Key Topics Covered 

1.    Executive Summary

2.    Global Blood Glucose (SMBG) Users and Forecast

2.1    Number of Users & Forecast
2.2    Users Share and Forecast

3.    Global Blood Glucose (SMBG) Market (2010 – 2024) 

3.1    Blood Glucose Device Market & Forecast
3.2    Test Strips Market and Forecast
3.3    Lancet Market and Forecast
3.4    Blood Glucose Meter Market and Forecast

4.    Market Share – Blood Glucose Devices (SMBG) (2010 – 2024) 

4.1    Blood Glucose Device Market Share & Forecast
4.2    Test Strips Market Share and Forecast
4.3    Lancet Market Share and Forecast
4.4    Meter Market Share and Forecast
4.5    Companies Share – Blood Glucose (SMBG) Revenue Share Analysis

5.    United States

5.1    United States Diabetes Population (2010 – 2024) 
5.2    Blood Glucose (SMBG) Users and Forecast
5.3    Blood Glucose Device (SMBG) Market and Forecast
5.4    Reimbursement of Blood Glucose Devices in United States

6.    United Kingdom

6.1    United Kingdom Diabetes Population (2010 – 2024) 
6.2    Blood Glucose Device (SMBG) Users and Forecast
6.3    Blood Glucose Device (SMBG) Market and Forecast
6.4    Reimbursement of Blood Glucose Devices in United Kingdom

7.    Germany

7.1    Germany Diabetes Population (2010 – 2024) 
7.2    Blood Glucose Devices (SMBG) Users (2010 – 2024) 
7.3    Blood Glucose Devices (SMBG) Market (2010 – 2024) 
7.4    Reimbursement of Blood Glucose Devices in Germany

8.    Spain

8.1    Spain Diabetes Population (2010 – 2024) 
8.2    Blood Glucose Device (SMBG) Users and Forecast
8.3    Blood Glucose Devices (SMBG) Market (2010 – 2024) 
8.4    Reimbursement of Blood Glucose Devices in Spain

9.    Italy

9.1    Italy Diabetes Population (2010 – 2024) 
9.2    Italy Self-Monitoring of Blood Glucose (SMBG) Users (2010 – 2024) 
9.3    Blood Glucose (SMBG) Market (2010 – 2024) 
9.4    Reimbursement of Blood Glucose Devices in Italy

10.    Netherlands

10.1    Netherlands Diabetes Population (2010 – 2024) 
10.2    Blood Glucose Devices (SMBG) Users and Forecast
10.3    Blood Glucose Devices (SMBG) Market (2010 – 2024) 
10.4    Reimbursement of Blood Glucose Devices in Netherlands

11.    Norway

11.1    Norway Diabetes Population (2010 – 2024) 
11.2    Blood Glucose Devices (SMBG) Users and Forecast
11.3    Blood Glucose Devices (SMBG) Market and Forecast
11.4    Reimbursement of Blood Glucose Devices in Norway

12.    Sweden

12.1    Sweden Diabetes Population (2010 – 2024) 
12.2    Blood Glucose Device (SMBG) Users and Forecast
12.3    Blood Glucose (SMBG) Market (2010 – 2024) 
12.4    Reimbursement of Blood Glucose Devices in Sweden

13.    Switzerland

13.1    Switzerland Diabetes Population (2010 – 2024) 
13.2    Blood Glucose Devices (SMBG) Users and Forecast
13.3    Blood Glucose Devices (SMBG) Market (2010 – 2024) 
13.4    Reimbursement of Blood Glucose Devices in Switzerland

14.    Russia

14.1    Russia Diabetes Population (2010 – 2024) 
14.2    Blood Glucose Devices (SMBG) Users and Forecast
14.3    Blood Glucose (SMBG) Market (2010 – 2024) 
14.4    Reimbursement of Blood Glucose Devices in Russia

15.    Brazil

15.1    Brazil Diabetes Population (2010 – 2024) 
15.2    Blood Glucose Devices (SMBG) Users and Forecast
15.3    Blood Glucose Devices (SMBG) Market and Forecast
15.4    Reimbursement of Blood Glucose Devices in Brazil

16.    India

16.1    India Diabetes Population (2010 – 2024) 
16.2    Blood Glucose Devices (SMBG) Users and Forecast
16.3    Blood Glucose Devices (SMBG) Market (2010 – 2024) 

17.    China

17.1    China Diabetes Population (2010 – 2024) 
17.2    Blood Glucose Devices (SMBG) Users (2010 – 2024) 
17.3    Blood Glucose Devices (SMBG) Market and Forecast

18.    Australia

18.1    Australia Diabetes Population (2010 – 2024) 
18.2    Blood Glucose Devices (SMBG) Users and Forecast
18.3    Blood Glucose Devices (SMBG) Market and Forecast
18.4    Reimbursement of Blood Glucose Devices in Australia

19.    Kuwait

19.1    Kuwait Diabetes Population (2010 – 2024) 
19.2    Blood Glucose Devices (SMBG) Users (2010 – 2024) 
19.3    Blood Glucose Devices (SMBG) Market and Forecast

20.    Growth Factors for Blood Glucose Devices (Due to data confidentiality, growth factors have not been disclosed in this table of contents)

20.1    Point No. 1
20.2    Point No. 2
20.3    Point No. 3
20.4    Point No. 4

21.    Challenges of Blood Glucose Devices Market (Due to data confidentiality, challenges have not been disclosed in this table of contents)

21.1    Point No. 1
21.2    Point No. 2

22.    Company Analysis

22.1    Roche Diagnostic
22.2    LifeScan Inc. 
22.3    Bayer HealthCare
22.4    Abbott Laboratories
 

About Us

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Contact Us

Renub Research

Phone: +1-678-302-0700

Email: info@renub.com

Website: https://www.renub.com     

Follow us on LinkedIn: https://www.linkedin.com/company/renub-research